Inactive Instrument

Insiders Adamas Pharmaceuticals, Inc.

Equities

Adamas Pharmaceuticals, Inc. Announces Management Changes	21-11-24	CI
Adamas Pharmaceuticals : Named 2021 Finalist in the New Therapeutics Category of the UCSF Health Awards	21-10-01	BU
Adamas Pharmaceuticals, Inc. Announces the Resignation of Mardi C. Dier from the Board of Directors	21-06-11	CI
Adamas Pharmaceuticals, Inc. Announces Changes to Its Board of Directors	20-11-23	CI
Adamas Pharmaceuticals, Inc. Appoints Adrian Quartel, Md as Chief Medical Officer	20-10-01	CI
Adamas Pharmaceuticals, Inc. Appoints Anna Richo as Member of the Board	20-09-01	CI
Adamas Pharmaceuticals, Inc. Announces Management Changes	20-01-08	CI
Adamas Pharmaceuticals, Inc. Announces Management Changes	19-09-13	CI
Adamas Pharmaceuticals, Inc. Announces Executive Changes	19-08-08	CI
Adamas Pharmaceuticals, Inc. Appoints Vijay Shreedhar as Chief Commercial Officer	19-05-31	CI
Adamas Pharmaceuticals, Inc. Announces Executive Changes	18-09-14	CI
Adamas Pharmaceuticals, Inc. Announces Board Changes	17-10-11	CI
Adamas Pharmaceuticals, Inc. Announces Management Changes	17-09-21	CI
Adamas Pharmaceuticals, Inc. Appoints Richard A. King as Chief Operating Officer	17-04-27	CI
Adamas Appoints Michael F. Bigham to Board of Directors	16-09-22	CI
Adamas Pharmaceuticals, Inc. Announce Board Changes	16-03-24	CI
Adamas Pharmaceuticals, Inc. Announces Executive Changes, Effective January 29, 2016	15-12-10	CI
Adamas Pharmaceuticals, Inc. Announces Management Changes	14-08-13	CI

No results for this search